UPCOMING SESSIONS in ET

Fri, Jul 17, 2026

5:00 – 6:00 AM Bangkok

Part 1: Making Meaning from What Has Been (Past) Hamide Eygoren Click Here To Register

UPCOMING SESSIONS in ET

Fri, Jul 17, 2026 · 5:00 – 6:00 AM Bangkok

Part 1: Making Meaning from What Has Been (Past)

Hamide Eygoren

Click Here To Register

View all sessions

Baim Institute for Clinical Research

Published: Jul 15, 2026

Category

Source

https://www.linkedin.com/posts/baim-institute-for-clinical-research_defining-heart-failure-endpoint-in-attr-amyloidosis-activity-7482856217631956992-8GBf

Details

Defining Heart Failure Endpoint in ATTR Amyloidosis Clinical Trials: Time for an Update?

https://lnkd.in/gubbdj6x Contributions from Baim CSO, James Januzzi and Baim faculty, Kenneth Mahaffey.

Newsletter

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion

Featured Trials